Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1990 Mar;29(3):363–365. doi: 10.1111/j.1365-2125.1990.tb03649.x

The effect of sulindac on dermal responses to bradykinin in normal subjects given an angiotensin converting enzyme inhibitor.

R E Ferner 1, F Kamali 1, M D Rawlins 1
PMCID: PMC1380139  PMID: 2310660

Abstract

The ability of sulindac to modify the weal response to four doses of intradermal bradykinin in subjects given enalapril was tested in a double-blind cross-over study in normal volunteers. The dose-dependent increase in skin thickness after bradykinin was significantly reduced by prior administration of sulindac. Certain of the actions and adverse effects of angiotensin converting enzyme inhibitors may be due to the interaction of prostaglandins and bradykinin.

Full text

PDF
363

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Crossman D. C., Fuller R. W. Bradykinin induced wheal and flare is not mediated by histamine release or cyclooxygenase products. Br J Clin Pharmacol. 1988 Jul;26(1):113–115. doi: 10.1111/j.1365-2125.1988.tb03375.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ferner R. E., Simpson J. M., Rawlins M. D. Effects of intradermal bradykinin after inhibition of angiotensin converting enzyme. Br Med J (Clin Res Ed) 1987 May 2;294(6580):1119–1120. doi: 10.1136/bmj.294.6580.1119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Ferner R. E., Wilson D., Paterson J. R., Wilkinson R., Rawlins M. D. The effects of intradermal bradykinin are potentiated by angiotensin converting enzyme inhibitors in hypertensive patients. Br J Clin Pharmacol. 1989 Mar;27(3):337–342. doi: 10.1111/j.1365-2125.1989.tb05374.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Fuller R. W., Dixon C. M., Cuss F. M., Barnes P. J. Bradykinin-induced bronchoconstriction in humans. Mode of action. Am Rev Respir Dis. 1987 Jan;135(1):176–180. doi: 10.1164/arrd.1987.135.1.176. [DOI] [PubMed] [Google Scholar]
  5. Heavey D. J., Barrow S. E., Hickling N. E., Ritter J. M. Aspirin causes short-lived inhibition of bradykinin-stimulated prostacyclin production in man. Nature. 1985 Nov 14;318(6042):186–188. doi: 10.1038/318186a0. [DOI] [PubMed] [Google Scholar]
  6. McAlpine L. G., Thomson N. C. The effect of indomethacin and enalapril on the cutaneous response to bradykinin. Br J Clin Pharmacol. 1989 Jun;27(6):870–872. doi: 10.1111/j.1365-2125.1989.tb03452.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Nicholls M. G., Gilchrist N. L. Sulindac and cough induced by converting enzyme inhibitors. Lancet. 1987 Apr 11;1(8537):872–872. doi: 10.1016/s0140-6736(87)91663-1. [DOI] [PubMed] [Google Scholar]
  8. Williams T. J. Prostaglandin E2, prostaglandin I2 and the vascular changes of inflammation. Br J Pharmacol. 1979 Mar;65(3):517–524. doi: 10.1111/j.1476-5381.1979.tb07860.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES